Nonlinear response surface in the study of interaction analysis of three combination drugs

Few articles have been written on analyzing three‐way interactions between drugs. It may seem to be quite straightforward to extend a statistical method from two‐drugs to three‐drugs. However, there may exist more complex nonlinear response surface of the interaction index (II) with more complex loc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biometrical journal 2017-01, Vol.59 (1), p.9-24
Hauptverfasser: Wan, Wen, Pei, Xin‐Yan, Grant, Steven, Birch, Jeffrey B., Felthousen, Jessica, Dai, Yun, Fang, Hong‐Bin, Tan, Ming, Sun, Shumei
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Few articles have been written on analyzing three‐way interactions between drugs. It may seem to be quite straightforward to extend a statistical method from two‐drugs to three‐drugs. However, there may exist more complex nonlinear response surface of the interaction index (II) with more complex local synergy and/or local antagonism interspersed in different regions of drug combinations in a three‐drug study, compared in a two‐drug study. In addition, it is not possible to obtain a four‐dimensional (4D) response surface plot for a three‐drug study. We propose an analysis procedure to construct the dose combination regions of interest (say, the synergistic areas with II≤0.9). First, use the model robust regression method (MRR), a semiparametric method, to fit the entire response surface of the II, which allows to fit a complex response surface with local synergy/antagonism. Second, we run a modified genetic algorithm (MGA), a stochastic optimization method, many times with different random seeds, to allow to collect as many feasible points as possible that satisfy the estimated values of II≤0.9. Last, all these feasible points are used to construct the approximate dose regions of interest in a 3D. A case study with three anti‐cancer drugs in an in vitro experiment is employed to illustrate how to find the dose regions of interest.
ISSN:0323-3847
1521-4036
DOI:10.1002/bimj.201500021